NCT02036229

Topical 0.5% Ivermectin Cream for Treatment of Demodicidosis

a Randomised, Double Blind, Placebo Controlled, Half- Face Study to Evaluate the Effect of Topical Ivermectin Cream 0.5% on Demodicidosis

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Rabin Medical Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether 0.5% ivermectin cream is effective in the treatment of demodicidosis (including papulopustular rosacea)

Conditions

• Demodicidosis
• Rosacea

Interventions

Type	Name	Description
DRUG	ivermectin cream 0.5%	Each participant will be treated with topical ivermectin cream 0.5% qd for one half of the face and with a vehicle cream qd for the other half of the face for 1 month. In the second month all patients will be treated with ivermectin cream for the entire skin involvement.

Timeline

• Start date: 2014-02-01
• Primary completion: 2015-12-01
• Completion: 2016-06-01
• First posted: 2014-01-14
• Last updated: 2015-01-13

Locations

1 site across 1 country: Israel